rilzabrutinib

Patients with moderate to severe chronic spontaneous urticaria that were antihistamine-resistant to omalizumab demonstrated efficacy and a rapid onset of action with rilzabrutinib. | Image Credit: kanachaifoto – stock.adobe.com Rilzabrutinib demonstrated significant efficacy and a rapid onset of action in alleviating itch and hives in patients with moderate to severe chronic spontaneous urticaria (CSU) whose … Read more